The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, June 18, 2020 - According to the requirements of art. 111, para. 8 of LPOS “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that due to a technical error in the Notification for treasury shares, number 194-00-31 / 16.06.2020 should be read:
Sofia, Bulgaria, June 16, 2020 – “Sopharma” AD notifies that to improve the operational management of the Company the Board of Directors assigned Mr. Simeon Donev, Director Business Development of “Sopharma” AD as a procurator.
Sofia, Bulgaria, June 16, 2020 - Sopharma AD notifies that on June 15, 2020 the Company bought 85 748 own shares representing 0.0636% of the share capital of the Company, at a total value of 277 823,52 BGN on the Bulgarian Stock Exchange, the average price per share was 3.240 BGN.
The total number of treasury shares after this transaction is 9 285 963, representing 6.89% of the share capital of the Company.